Kenneth Lock

Corporate Officer/Principal bei ACELYRIN, INC.

Vermögen: 212 795 $ am 31.05.2024

50 Jahre

Health Technology

Consumer Services

Aktive Positionen von Kenneth Lock

Unternehmen	Position	Beginn	Ende
ACELYRIN, INC.	Corporate Officer/Principal	18.07.2023	-

Unternehmen	Position	Beginn	Ende
ARCUTIS BIOTHERAPEUTICS, INC.	Corporate Officer/Principal	01.01.2020	02.06.2023
GILEAD SCIENCES, INC.	Vertrieb & Marketing	01.12.2013	01.08.2019
AMGEN INC.	Corporate Officer/Principal	01.03.2007	01.11.2013
Wyeth Pharmaceuticals, Inc. Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.	Corporate Officer/Principal	01.06.2003	01.02.2007
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Corporate Officer/Principal	01.01.1996	-

Cornell University	Masters Business Admin
University of California San Diego	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	5
Sales & Marketing	1
Masters Business Admin	1

Sektoral

Health Technology	7
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
ARCUTIS BIOTHERAPEUTICS, INC.	Health Technology
GILEAD SCIENCES, INC.	Health Technology
AMGEN INC.	Health Technology
ACELYRIN, INC.	Health Technology

Private Unternehmen	2
Wyeth Pharmaceuticals, Inc. Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.	Health Technology
IDEC Pharmaceuticals Corp. IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA.	Health Technology

Private Unternehmen

Health Technology